Reviewing Arrive AI (NASDAQ:ARAI) & Firefly Neuroscience (NASDAQ:AIFF)

Arrive AI (NASDAQ:ARAI) and Firefly Neuroscience (NASDAQ:AIFF) are both small-cap business services companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, profitability, dividends, analyst recommendations, earnings, institutional ownership and valuation.

Analyst Ratings

This is a summary of current ratings and target prices for Arrive AI and Firefly Neuroscience, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Arrive AI	1	0	1	0	2.00
Firefly Neuroscience	1	0	0	0	1.00

Arrive AI presently has a consensus price target of $12.00, indicating a potential upside of 1,516.81%. Given Arrive AI’s stronger consensus rating and higher probable upside, equities research analysts plainly believe Arrive AI is more favorable than Firefly Neuroscience.

Insider & Institutional Ownership

5.0% of Firefly Neuroscience shares are held by institutional investors. 6.4% of Firefly Neuroscience shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares Arrive AI and Firefly Neuroscience’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Arrive AI	N/A	-176.63%	-83.87%
Firefly Neuroscience	-1,740.98%	-229.99%	-158.47%

Earnings & Valuation

This table compares Arrive AI and Firefly Neuroscience”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Arrive AI	$110,000.00	245.87	-$12.83 million	($0.41)	-1.81
Firefly Neuroscience	$1.14 million	26.73	-$19.88 million	($1.80)	-1.14

Arrive AI has higher earnings, but lower revenue than Firefly Neuroscience. Arrive AI is trading at a lower price-to-earnings ratio than Firefly Neuroscience, indicating that it is currently the more affordable of the two stocks.

Summary

Arrive AI beats Firefly Neuroscience on 9 of the 13 factors compared between the two stocks.

About Arrive AI

We were incorporated on April 30, 2020, in the State of Delaware under the name of Dronedek Corporation. The Company changed its name to Arrive Technology Inc. on July 27, 2023. The Company changed its name to Arrive AI Inc. on September 30, 2024. We are a developmental technology company with a focus on designing and implementing a commercially viable smart mailbox and platform system for smart, secure, and seamless exchange of packages, goods, supplies, food, and medications between people, through the use of robots, and drones. We have not started conducting commercial operations and we had no revenues for fiscal years 2022, 2023 or 2024. Arrive executed an exclusive patent license agreement on May 26, 2020 with its CEO, Mr. O’Toole and amended in December 2024 and March 2025, whereby Mr. O’Toole granted Arrive rights to use, sell, manufacture and otherwise commercialize certain technologies relating to secured drone delivery ALM mailboxes in exchange for license fees. Such technologies helped jumpstart our business operations and will continue to play such a critical role in our growth that we became heavily reliant on the right to use them. Our corporate address is in Fishers, Indiana.

About Firefly Neuroscience

Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.